AKT1 and neoplasm: Activating alterations in receptor tyrosine kinases and downstream effectors converge on core signaling cascades, including the RAS–RAF–MEK–ERK, PI3K–AKT–mTOR, and JAK–STAT pathways, promoting tumor cell proliferation, angiogenesis, and survival.